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Abstract
   Despite the huge costs of ischemic neuronal injury, neuroprotective interventions in humans 
remain elusive, in part reflecting incomplete knowledge of the critical early events. Emerging 
evidence implicates Zn2+ as an important early contributor.  CA1 pyramidal neurons undergo 
selective delayed degeneration after transient global ischemia (TGI), and Zn2+ has been 
implicated in the injury. In vitro studies have indicated that Zn2+ enters mitochondria and has 
potent effects on their function. In addition, Zn2+ accumulates in CA1 mitochondria after ischemia
in hippocampal slice and whole animal models, and appears to contribute to their dysfunction.  
However, the relationship between mitochondrial Zn2+ accumulation and their disruption has not 
been examined at the ultrastructural level in vivo, reflecting the difficulty in assessing dynamics 
of labile (loosely bound) Zn2+. We employ a cardiac arrest model of ischemia, combined with 
Timm’s sulfide silver labeling, which inserts electron dense metallic silver granules at sites of 
labile Zn2+ accumulation, and use transmission electron microscopy (TEM) to examine subcellular
loci of the Zn2+ accumulation. In line with prior studies, TGI induced damage to CA1 was far 
greater than to CA3 pyramidal neurons, and was substantially progressive in the hours after 
reperfusion (being significantly greater after 4 than 1 h recovery). Intriguingly, TEM examination 
of Timm stained sections revealed substantial Zn2+ accumulation in many post-ischemic CA1 
mitochondria, which was strongly correlated with their swelling and disruption. Furthermore, 
paralleling the evolution of neuronal injury, both the number of mitochondria containing Zn2+ and
the degree of their disruption were far greater at 4 than 1 h recovery. These data provide the 
first direct characterization of Zn2+ accumulation in CA1 mitochondria after in vivo TGI, and 
further support the idea that mitochondria constitute an early and potentially targetable locus of 
Zn2+ effects in ischemia that contributes to mitochondrial damage and neuronal injury. 
Keywords:  zinc; excitotoxicity; mitochondria; ischemia; rat; stroke; hippocampus
Abbreviations:  cardiac arrest (CA); cardiopulmonary resuscitation (CPR); hippocampal 
pyramidal neuron (HPN); metallothionein (MT); mitochondrial Ca2+ uniporter (MCU); N-methyl-D-
aspartate (NMDA); outer membrane (OM); oxygen glucose deprivation (OGD); paraformaldehyde 
(PFA); phosphate buffered saline (PBS); Toluidine blue (TB); transient global ischemia (TGI); 
transmission electron microscopy (TEM); vanadium acid fuchsin (VAF).
Introduction
Brain ischemia is a leading cause of death and disability worldwide, but there are as yet no 
effective neuroprotective therapies. Many studies implicate “excitotoxicity” caused by excessive 
glutamate release as an important contributor and have largely focused on consequences of 
rapid Ca2+ entry through NMDA receptors. However, NMDA targeted therapies have shown 
limited clinical efficacy [1, 2]. Further studies have implicated contributions of another divalent 
cation, Zn2+ [3-7]. Despite high total levels of brain Zn2+ (100-200 µM), almost all of it is bound or
sequestered, and free cytosolic levels are generally subnanomolar. However, a small portion 
(~10%) of brain Zn2+ is loosely bound (termed labile Zn2+); this pool largely comprises Zn2+ 
present in certain pre-synaptic vesicles (most conspicuously in the mossy fiber pathway) [8], 
from which it can be co-released with glutamate upon synaptic activation [9-11], and can be 
visualized using a histochemical technique (Timm’s sulfide silver labeling), or with membrane 
permeant fluorescent indicators [8, 12, 13]. Indeed, indicating its specificity, Timm’s labeling is 
completely absent in brains of knockout mice lacking the vesicular Zn2+ transporter, ZnT3 [14]. In
pathological conditions of ischemia or prolonged seizures, associated with strong synaptic 
activation, there is release of this presynaptic Zn2+, along with appearance of new labile Zn2+ in 
somata of some hippocampal pyramidal neurons (and other forebrain neurons)[3-5, 11], 
reflecting a combination of synaptically released Zn2+ that can enter postsynaptic neurons 
through various routes (“Zn2+ translocation”), and Zn2+ mobilization from buffers (particularly 
metallothionein-III; MT-III) already present in the postsynaptic neurons, in response to oxidative 
stress and acidosis [15, 16].
   However, the redistribution of labile Zn2+ has never been examined at the ultrastructural level. 
Multiple studies have indicated that Zn2+ can induce potent effects on mitochondria in vitro and 
after transient ischemia in vivo [6, 16-19]. In addition, we have carried out studies using 
hippocampal slices subjected to prolonged oxygen glucose deprivation (OGD) to model acute 
ischemia, and found that early cytosolic Zn2+ rises and mitochondrial Zn2+ entry appears to 
contribute to the acute hippocampal pyramidal neuron (HPN) injury [20, 21]. Furthermore, after 
shorter (sublethal) episodes of OGD, there was a gradual recovery of the early cytosolic Zn2+ 
elevations accompanied by progressive and persistent Zn2+ accumulation in mitochondria of CA1
(but not CA3) neurons, that appeared to contribute to delayed mitochondrial swelling [22], 
possibly consistent with the selective delayed degeneration of these neurons after transient 
ischemia [23-25] . However, whereas these in vitro observations support the possibility that 
mitochondria are critical loci of early Zn2+ effects in vivo, this question has not as yet been 
directly examined in animals.  
  In the present study, we employ a rat asphyxial cardiac arrest (CA) model of transient global 
ischemia (TGI), which provides the advantage over focal ischemia that the entire brain is 
subjected to the same duration of ischemia, such that regional differences in outcome largely 
reflect differences in susceptibility. Using this model system, we aimed, for the first time, to 
examine the redistribution of Zn2+ into mitochondria and its potential contribution to 
mitochondrial disruption and neuronal injury. Such a study requires an ultrastructural 
assessment, to correlate Zn2+ accumulation with morphology of individual mitochondria, and the 
presently employed technique of Timm’s labeling (which inserts electron dense silver deposits in
situ at subcellular sites of labile Zn2+ accumulation) combined with transmission electron 
microscopy (TEM) would seem ideally suited for such an investigation. Present findings, which 
show for the first time progressive Zn2+ accumulation in CA1 mitochondria after in vivo TGI to be 
strongly correlated with their physical disruption, provide new support for a direct contributory 
role of the mitochondrial Zn2+ in the delayed and progressive mitochondrial damage and cell 
death of these neurons. 
Materials and Methods
Ethics statement
This study was carried out in accordance with the recommendations from the Guide for the Care 
and Use of Laboratory Animals of the National Institutes of Health and approved by the 
Institutional Animal Care and Use Committee of the University of California, Irvine.  
Animals
Experiments were performed using male Wistar rats (Charles River Laboratories, Wilmington, MA)
weighing 300-350 g (approximately 8-12 weeks). After applying the inclusion criterion that chest 
compressions lasted shorter than 1min (as previously described) [26], the final number of rats 
included for data analysis was 25. Upon arrival, rats were maintained in a 12-h light/12-h dark 
(6:00 am/6:00 pm) cycle and fed standard rat chow.  They are handled for at least five days for 
acclimation to the researchers and their new environment. 
Cardiac arrest and resuscitation
This study utilizes an asphyxial CA model largely as previously described [26, 27]. Rats were 
calorically restricted to 25% of normal food intake 14 h prior to CA experiment. Rats were 
intubated using a 14-gauge endotracheal tube (B. Braun Melsungen AG, Melsungen, Germany), 
connected to a TOPO mechanical ventilator (Kent Scientific, Torrington, CT) and isoflurane 
vaporizer for delivery of 2% isoflurane and 50% O2 and 50% N2 gas during surgical preparation 
for CA. Femoral artery and vein cannula allowed for monitoring of blood pressure and heart rate, 
and administration of intravenous medication. Invasive arterial blood pressure was measured 
continuously using a transducer (CWE Inc., Ardmore, PA).
   CA experiments began at “minute 0”, when the isoflurane level was reduced to 1-1.5% to 
prepare for anesthesia wash out and inhaled gas was switched to 100% O2. After two minutes, 
isoflurane was stopped to wash out anesthesia, neuromuscular blockade initiated with 1mL of 
intravenous Vecuronium (2mg/kg) injected with 1mL of heparinized saline, and the inlet was 
disconnected from oxygen to allow room air to be mechanically delivered to the rat. At minute 5, 
asphyxial CA was induced by turning the ventilator off and clamping the ventilator tubing. CA 
time was defined as systolic blood pressure less than 30 and pulse pressure of 10 or less. 
Baseline arterial blood gas (ABG) measurements (Abaxis, Union City, CA) were obtained within 
30 min prior to initiation of asphyxia. Durations of asphyxia were all between 8 and 9 minutes. In 
the last minute of asphyxia, as the ventilator is being reconnected and turned on, 0.4 ml 
epinephrine (0.01mg/kg) and 0.5 ml bicarbonate (1.0 mmol/kg) are given to stimulate the 
sympathetic nervous system and manage acidosis, respectively. Of 17 rats subjected to 
asphyxial CA used in the data analysis, the mean duration of asphyxia was 8.5 ± 0.1 min, 
yielding CA durations of 6.8 ± 0.2 min (mean ± SEM). Cardiopulmonary resuscitation (CPR, 
manual sternal compressions at 180-240 per minute) was performed and continued until return 
of spontaneous circulation (ROSC). ABGs were obtained 10-min post-ROSC, to assess ventilation 
and modify ventilator settings as necessary. Over the next 1 hr post ROSC vessels were 
decannulated and rats were extubated. 
VAF / toluidine blue staining and confocal imaging of mitochondrial morphology
One or 4 h after CPR, animals were anesthetized with isoflurane, and perfused transcardially with
phosphate buffered saline (PBS) for 2 min, followed by 4% paraformaldehyde (PFA) in PBS for 10
min. The brains were post-fixed in 4% PFA /1% gluteraldehyde for 72 h, then PFA was exchanged 
for 30% sucrose (in PBS) for another 2 days, 30 μm brain sections containing hippocampus were 
cut using a cryostat (ThermoFisher Scientific).  
    To assess neuronal injury, sections were stained with vanadium acid fuchsin (VAF)/toluidine 
blue (toluidine blue (TB) largely as described [28]. In brief, slices were stained with VAF for 1-2 
min, washed with PBS, incubated in 0.01% borax solution for 20-30 second, and rinsed in distilled
water. Finally, brain slices were cleared by acetate buffer (PH 3.3) for 30 seconds and 
counterstained with 0.025% toluidine blue for 20-30 seconds. Stained slices were assessed using 
light microscopy. 
   To assess mitochondrial morphology, sections were labeled with primary antibodies against the
mitochondrial outer membrane protein, translocase outer membrane-20 (TOM20; 1:200; Santa 
Cruz Biotechnology) and secondary anti-rabbit fluorescent antibodies (1:200, DyLight 488; 
Jackson ImmunoResearch). The sections were imaged using an inverted stage Nikon Eclipse Ti 
chassis microscope with a Yokogawa CSUX spinning disk head and a 100× (1.49 numerical 
aperture) objective and images acquired using a Hamamatsu electromultiplying CCD camera. 
Excitation (488 nm) was via a Coherent sapphire laser source synchronized with the camera, 
emission was monitored with a 525 (50) nm filter, and images were acquired using MIcroManager
ImageAcquisition sofrware (version 1.4.16). 
Cardiac perfusion and tissue sections preparation for Timm’s labeling
In initial studies, brain sections were prepared in 2 ways (as outlined in Results). Our first 
attempts sought to maximize rapid Zn2+ fixation in situ; animals were perfused with 0.2% Na2S in
Millonig’s buffer for 5 min to precipitate Zn2+, followed by 4% PFA / 1% glutaraldehyde solution in 
PBS for the next 12 min. After perfusion the brains were removed and post-fixed using 2% PFA / 
2% glutaraldehyde / 0.2% Na2S, 4°C for 72 h, then placed into 30% sucrose solution in PBS for 
48-72 h, followed by OCT embedding and cryostat sectioning (to 50 or 80 μm thickness). 
Subsequent studies sought to optimize tissue preservation – to that aim rats were perfused 
transcardially with 4% PFA / 1% glutaraldehyde solution in PBS for 5 min, followed by 0.4% Na2S /
Millonig’s buffer (0.12M; 0.002% CaCl2, 1.6% NaH2PO4 and 0.4% NaOH; PH 7.3) for next 7 min to 
precipitate Zn2+ [29].  Brains were removed and post-fixed using 2% PFA / 2% glutaraldehyde / 
0.2% Na2S, 4°C overnight, prior to vibratome sectioning (again to 50 or 80 μm thickness). 
   For Timm’s staining, slices were incubated in the dark in a solution containing 1 part solution A 
(1M AgNO3), 20 parts solution B (2% hydroquinone and 5% citric acid in water), and 100 parts of 
solution C (30% gum arabic in water). Development was performed in the dark, was monitored 
by periodic evaluations under low light, and was terminated by washing in water. 80 μm slices 
were placed into PBS and processed for electron microscopy; 50 μm slices were analyzed under 
light microscopy.    
Electron microscopy
For TEM analysis, we utilized ultrathin sections (~1 µm thickness) from vibrotome or cryostat cut 
fixed brain slices, prepared largely as previously described [30] with small modifications. The 
sections were rinsed in PBS and post-fixed with 1% osmium tetroxide in PBS for 1 hour, then 
dehydrated in increasing serial dilutions of ethanol (70%, 85%, 95%, 100%), put into 
intermediate solvent propylene oxide (2 times for 10 min), and incubated in 1:1 mixture of 
propylene oxide/Spurr's resin for 1 h. Finally slices were embedded in Spurr’s resin overnight. 
Ultrathin sections (~70nm thickness) were cut using a Leica Ultracut UCT ultramicrotome (Leica, 
Vienna, Austria) mounted on 150 mesh copper grids, stained with lead citrate and viewed using a
JEOL 1400 electron microscope (JEOL, Tokyo, Japan). Images were captured using a Gatan digital 
camera (Gatan, Pleasanton, CA, USA).
Statistics and data analysis
All counts / ratings were carried out entirely by raters blinded to the experimental conditions 
(TEM, TOM-20), or verified via extensive sampling by blinded raters (VAF/TB).  
   For assessment of neuronal injury (VAF/TB) photomicrographs (40 x magnification) were 
obtained from each section. The rater examined the micrographs, and judged each identifiable 
neuron in the section as healthy or injured based upon criteria as described.  For mitochondrial 
ratings of TEM images of sections from CA1, all evident mitochondria in images from CA1 
pyramidal neurons were rated as to the presence of Timm’s stain deposits (representing Zn2+) 
and the integrity of the mitochondria, according to criteria as described. For measurement of 
TOM-20 labeled mitochondria, large neurons in the pyramidal cell layer were imaged using 
confocal microscopy. To control for differing behavior of mitochondria between cellular 
compartments, we focused our studies on mitochondria in the perinuclear region, in the plane of 
sharp focus. Images were imported into ImageJ software, and were adjusted to provide optimal 
discrimination of the apparent mitochondrial edges from background. Length and width 
measurements were obtained on all clearly demarcated mitochondria adjacent to and 
surrounding the nuclear circumference. 
   To assess significance, either two-tailed t-test or one-way ANOVA with Tukey post-hoc analysis 
(indicated in each figure legend) was used, depending on the number of groups of comparison. 
All values are displayed as mean ± standard error of the mean (SEM). All experiments were 
repeated at least 3 times.
Results
HPN injury after transient global ischemia (TGI)
     Rats were subjected to asphyxial cardiac arrest (CA) as described (see Materials and 
Methods).  After resuscitation followed by 1 h or 4 h of recovery, rats were perfused, and their 
hippocampi processed for histological analysis.  
     To assess overall injury to CA1 and CA3 pyramidal neurons, sections were stained with a 
modified acid fuchsin labeling procedure to identify acidophilic neurons (termed vanadium acid 
fuchsin, VAF labeling) [28], and counter stained with toluidine blue (TB; to assess morphology). 
Sections were examined and each identifiable neuron rated as healthy or injured. Healthy 
neurons showed distinct round nuclei surrounded by TB stained cytoplasm. Injured neurons were 
of two types; one subset that showed clear atrophy along with VAF (acidophilic) labeling in the 
cytoplasm indicative of early injury, whereas others showed severe swelling with loss of clear 
distinction between nucleus and surrounding cytoplasm, vacuolar changes,  and absence of clear
VAF labeling (Fig. 1A, Left). We noted that in comparison to control, episodes of global ischemia
caused distinct and substantial injury to CA1 pyramidal neurons, with relatively little injury in 
CA3. In addition, the CA1 injury was greater after 4 h than after 1 h recovery, indicating apparent
progression of the injury in the hours after the ischemic episode (Fig. 1A, Right). 
     To begin to address our questions concerning possible Zn2+ contributions to the injury, some 
sections were stained with a modified Timm’s procedure (see Materials and Methods) to 
assess the presence and localization of labile Zn2+, and examined under conventional brightfield 
microscopy (Fig. 1B). As discussed above, the Timm’s technique detects labile or loosely bound 
Zn2+ in tissues by using sulfide ion to precipitate the Zn2+ and “developing” the label (much as 
with photographic prints) via reduction and deposition of metallic silver at loci of the ZnS 
precipitates, and in brain appears to be entirely selective for Zn2+ [8, 14]. Note that in control 
slices, distinct Timm’s labeling, indicative of labile Zn2+, is most prominent in the mossy fiber 
boutons in the dentate gyrus, the hilus and extending along the CA3 pyramidal cell layer, but 
that labeling is largely absent in neuronal somata.  Further note the substantial loss of Timm’s 
label from the mossy fibers 1 h after ischemia, with partial recovery of labeling after 4 h. Finally, 
note the appearance of weak Timm’s label in somata of CA1 neurons after ischemia that is 
greater with 4 than with 1 h recovery, indicative of some relocalization of labile Zn2+, paralleling 
the observed neuronal injury.  
Figure 1. Global ischemia induces progressive neuronal injury and Zn2+ accumulation 
in CA1 pyramidal neurons. Rats were subjected to TGI followed by resuscitation as described. 
After 1 or 4 h recovery, rats were euthanized, perfused, and brain tissue removed for histological 
examination as described. Injury was assessed on hippocampal slices subjected to a modified 
acid fuchsin labeling procedure (VAF; detailed in Methods) and counter stained with toluidine 
blue; Zn2+ accumulation was assessed via Timm’s labeling (see Materials and Methods).  
  A. Global ischemia induced injury to hippocampal CA1 pyramidal neurons.
Left: Representative images. Hippocampal slices were photographed at low magnification 
(Bar = 500 µm), and CA1 and CA3 regions (indicated by blue and red rectangles, respectively) 
examined at higher magnification (Bar = 50 µm).  While most neurons appear intact in control 
slices, note the increased numbers of VAF stained neurons as well as of severely swollen neurons
(with vacuolar changes and loss of distinct nuclear outlines) after ischemia. Further note that 
these changes are more prevalent in CA1 than in CA3, and appear to increase from 1 to 4 h after
ischemia (particularly in CA1). Examples of intact (arrow) and damaged (VAF +, triangle; swelling
and vacuolar changes, circled) neurons are marked. 
Right:  Quantitative assessment.  All discernable neurons were rated as intact or injured, and
the percentages of CA1 and CA3 neurons determined to be injured within each hippocampal 
section were calculated. Note that the extent of neuronal injury was far greater in CA1 that in 
CA3, and that in CA1, it was significantly greater after 4 h than 1 h recovery.  Bars represent 
mean ± SEM from 4 – 7 independent animals (comprising ≥ 1000 cells from CA1; ≥ 500 from 
CA3; with ≥ 3 sections counted for each animal; ** indicates p < 0.01 by one way ANOVA with 
Tukey post hoc).
  B. Transient loss of mossy fiber Zn2+ and progressive Zn2+ accumulation in CA1 
pyramidal neurons after transient global ischemia. Photomicrographs show low 
magnification images of Timm’s labeled hippocampal sections (Bar = 500 µm), and greater 
magnification images of the CA1 regions from the same sections (indicated by rectangles; Bar = 
50 µm). Note the robust stain in the mossy fibers (indicative of presynaptic vesicular Zn2+) in 
control, and the substantial loss of this Zn2+ at 1 h recovery.  Further note the appearance of 
some Zn2+ in the somata of CA1 pyramidal neurons that progresses from 1 h to 4 h after 
ischemia (a small amount of accumulation was also noted in some CA3 pyramidal neurons, not 
shown; Images are representative of ≥ 3 repetitions each condition).
Transient global ischemia induces mitochondrial swelling
     Previous studies have suggested that mitochondria are likely to be important targets of Zn2+-
induced neuronal injury [19]. In light of our recent observations of protracted Zn2+ accumulation 
in CA1 mitochondria after OGD in hippocampal slice [22], we next sought to examine 
mitochondrial morphology in CA1 neurons after TGI. Sections were immunostained for the 
mitochondrial outer membrane marker, TOM-20, examined under confocal microscopy (1000x), 
and images obtained in the CA1 and CA3 pyramidal layers, largely as previously described [22]. 
For quantitative assessment, images were adjusted (using Image J software) to optimally 
discriminate mitochondrial borders from background, and perinuclear regions cropped from 
images and coded for blinded measurement of mitochondrial lengths and widths (see Materials 
and Methods). We found that OGD caused a marked “rounding-up” of the mitochondria with 
substantial decreases in their mean lengths, increases in their widths, and decreased length / 
width (L/W) ratios. Notably, whereas direct visual examination of the microscope fields yielded an
impression that mitochondrial swelling and disruption were worse in CA1 that in CA3, and were 
greater after 4 than 1 h recovery, the quantification procedure did not confirm these differences 
(showing substantially decreased L/W ratios in all ischemic conditions) (Fig. 2). This was felt to 
reflect a limitation of the approach – as only mitochondria with distinct visualization of edges 
were amenable to measurement – and extreme swelling and consequent blurring of the borders 
of the most effected mitochondria precluded accurate assessment of levels of swelling towards 
the extreme end of the scale.  
Figure 2. Ischemia disrupts mitochondrial morphology in CA1 pyramidal neurons.
Rats were subjected to TGI followed by 1 or 4h recovery.  Hippocampal slices were 
immunostained using antibody against the mitochondrial outer membrane marker, TOM20, and 
examined under confocal microscopy (1000x). 
A-C: Representative images of TOM20-labeled CA1 mitochondria. Note the generally 
elongated mitochondria seen in perinuclear regions of control (A), in contrast to the abundant 
fragmented and swollen mitochondria 1 or 4 h after ischemia (B and C; Bar = 10 µm).
D: Ischemia impacts mitochondrial morphology. Lengths and widths of individual 
mitochondria were measured blindly (using ImageJ software) and length/width (L/W) ratios 
calculated to quantify morphological change (lower L/W ratios indicates rounding of 
mitochondria).  The L/W ratio for all mitochondria measured in neurons from a single animal were
averaged to produce a single, mean L/W ratio for that animal.  Note the significant decrease in L/
W ratio after ischemia. Bars represent mean L/W ratio ± SEM from 4 – 6 independent animals 
each condition (comprising 125 mitochondria from 38 cells, control; ≥ 250 mitochondria, from ≥ 
60 cells per group after TGI; ** indicates p < 0.01 by one way ANOVA with Tukey post hoc).  
Ischemia-induced mitochondrial Zn2+ accumulation correlates with ultrastructural disruption  
     We next set out to use the Timm’s sulfide silver labeling technique to localize sites of 
neuronal Zn2+ accumulation at an ultrastructural level.  As indicated above, this technique inserts
metallic silver deposits at sites of labile or loosely bound Zn2+ accumulation.  Staining in neurons 
is considered to be quite specific for Zn2+, and was found to be entirely absent in mice lacking 
the vesicular Zn2+ transporter (ZnT3 knockout mice) [14].  In control studies seeking to further 
validate the Zn2+ specificity of the stain, we made use of the well characterized hippocampal 
slice oxygen glucose deprivation (OGD) model of brain ischemia [20-22].  As in Fig. 1B, in control 
slices Timm staining was present in the mossy fiber pathway but was completely absent in the 
pyramidal cell layer, but distinct label appeared in the pyramidal cell layer after a brief (8 min) 
episode of OGD.  However, when the slices were perfused with the Zn2+ preferring chelator, 
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN) after OGD, the Timm’s label was 
markedly diminished (data not shown) , providing further support to the contention that the 
Timm’s stain largely reflects accumulation of labile Zn2+ in post-synaptic neurons, as has been 
previously described.   
     Timm’s labeled slices were subjected to TEM examination in order to investigate the 
redistribution of labile Zn2+ in the somata of CA1 pyramidal neurons in rats subjected to TGI as 
above. This approach is particularly well suited for the ultrastructural examination of Zn2+ 
localization, as the silver deposit is electron dense and thus easily visualized. Timm’s labeling 
and TEM examination are strongly dependent upon animal perfusion and tissue processing 
techniques. Prior studies have employed a number of variations to try to optimize both the 
visualization of the Zn2+ and the preservation of the tissue ultrastructure for TEM examination. A 
key component of Timm’s labeling is the early use of Na2S in the perfusion procedure to 
precipitate the labile Zn2+ in situ. In early trials we carried out two distinct variations (see 
Materials and Methods for full details): 1. Initial perfusion with Na2S (0.2% in buffer, 5 min) 
prior to perfusion with PFA/glutaraldehyde, in order to maximize Zn2+ detection by fixing it in situ 
at the earliest possible time point; or 2. Perfusion with PFA/glutaraldehyde (5 min) prior to Na2S 
(0.4%, 7 min), in order to optimize tissue preservation. In both cases perfusion was followed by 
brain removal and post-fixation incorporating PFA, glutaraldehyde, and Na2S.  In control slices 
subjected to these two perfusion protocols we noted no qualitative difference in the appearance 
or localization of the Timm’s label, and opted for the second approach (fixation first), which is the
more conservative in terms of Zn2+ detection, in subsequent experiments.  
     In our ultrastructural studies, hippocampal CA1 sections from 10 animals (3 controls, 4 
ischemia followed by 1 h recovery; 3 ischemia followed by 4 h recovery) were subjected to 
blinded quantitative examination. In agreement with prior studies [8, 14], in control rats, we 
found electron dense Zn2+ foci to be most evident in presynaptic mossy fiber boutons with little 
evidence of Zn2+ at other loci or within neuronal somata. In the controls, a substantial majority of
mitochondria appeared healthy and intact; these generally were elongated, and had distinct 
cristae structure visible along with an intact double outer membrane (Figs. 3A, 4A). However, a 
minority (~20-25%) showed evidence of mild injury; these were generally more round than 
elongated suggestive of early swelling, and often showed some disruption or blurring of their 
cristae. Interestingly, close to 50% of these mildly damaged mitochondria contained apparent 
Zn2+ deposits, as indicated by the presence of electron dense silver granules similar to those 
seen in presynaptic boutons. In contrast, Zn2+ deposits were only seen in a very small fraction 
(<1%) of intact appearing mitochondria, in all conditions.  
     In comparison to the controls, the numbers of damaged mitochondria were substantially 
increased after global ischemia. With 1 h recovery, ~50% of mitochondria were damaged. 
Interestingly the damage appeared to be strongly progressive, with >75% of mitochondria 
showing damage after 4 h recovery. Furthermore, at
each of these recovery time points, the majority of 
damaged mitochondria had clear Zn2+ deposits 
(Fig. 3B) supporting a Zn2+ contribution to the 
mitochondrial damage. Yet, in each condition, a 
minority of damaged mitochondria lacked clear Zn2+
deposits. The reasons for this are not completely 
clear but may well reflect a number of factors, 
including: 1. A threshold level of Zn2+ accumulation 
may be needed for detection by the Timm’s labeling
procedure; 2. The use of our conservative perfusion
paradigm, which maximizes structural protection / 
integrity at the possible expense of some loss of 
Zn2+ from loci of intracellular accumulation, and 3. 
Contributions of Zn2+ independent mitochondrial 
swelling mechanisms. 
Figure 3.  Global ischemia induces progressive
Zn2+ accumulation and injury in CA1 pyramidal
neuronal mitochondria.  Rats were subjected to 
TGI followed by 1 or 4h recovery. To assess 
mitochondrial damage and Zn2+ accumulation in 
CA1 pyramidal neurons, Timm’s labeled 
hippocampal slices were examined under TEM.  
A.  Representative electron micrographs. 
Representative TEM images (4000x) of Timm’s 
labeled slices from a control rat (top), or rats 
subjected to ischemia followed by 1 h (middle), or 4
h (bottom) recovery (Bar = 0.5 µm; rectangles show
regions displayed at greater magnification, right; 
Bar = 0.5 µm) Note the intact structure and 
absence of Timm’s precipitate in most mitochondria
in control, the significant numbers of mitochondria 
showing early damage (with rounding) and distinct 
presence of Timm’s precipitate with 1 h recovery, 
with greater numbers of mitochondria displaying 
Zn2+ accumulation and extensive injury after 4 h 
recovery.
B.  Quantitative evaluation. To assess 
mitochondrial Zn2+ accumulation and damage, all evident mitochondria in images from CA1 
pyramidal neurons were rated by an observer blinded to the experimental condition. Bars display
percentage of mitochondria appearing intact or showing evidence of damage (assessed as 
described), and hatchmarks indicate the presence of evident Zn2+ deposits in the damaged 
mitochondria (Zn2+ deposits were only present in < 1% of intact appearing mitochondria, in all 
conditions). Note the marked increase in numbers of damaged appearing mitochondria after 
ischemia, the marked increase in their numbers with increased recovery duration (from 1 to 4 h),
and the parallel increase in numbers containing distinct Zn2+ deposits, present in the majority of 
damaged mitochondria in each condition. Values represent mean ± SEM from 3 – 4 independent 
animals each condition (for each animal, ≥ 70 mitochondria from ≥ 10 sections were rated; ** 
indicates p < 0.01 by one way ANOVA with Tukey post hoc).  
We further sought to discriminate degrees of mitochondrial damage related to mitochondrial Zn2+
accumulation (see Fig. 4). As noted above, all the damaged mitochondria showed evidence of 
mild swelling and early disruption of cristae structure. However, some showed more extreme 
disruption or even complete absence of evident cristae. In some there was apparent vacuole 
formation within mitochondria, whereas others showed varying degrees of outer membrane (OM)
rupture, progressing from a small area of rupture to complete loss of evident outer membrane. In
some mitochondria with apparent severe outer membrane rupture, there was apparent 
“leakage” of Zn2+ containing material into the surrounding cytoplasm (see images, Fig 4A). 
These characteristics are suggestive of progressive stages of mitochondrial damage.
     To further address the possible progression of the mitochondrial damage and disruption, we 
carried out a second blinded count and rating of mitochondria from the same set of post-
ischemic images, but only evaluating the mitochondria that both appeared damaged and 
contained Zn2+ precipitates. In this assessment we separated the mitochondria on the basis of 
the integrity of their OMs, considering that a ruptured OM reflected relatively severe and likely 
irrecoverable damage. Interestingly, we found the distribution of the mitochondrial damage to 
differ substantially between 1 and 4 h recovery, with the proportion of mitochondria with 
ruptured OMs being far greater with 4 h recovery (Fig. 4B).
Figure 4. Discrimination of degrees of mitochondrial damage: progression of 
mitochondrial disruption with time of recovery.    
A.  Graded degrees of mitochondrial structural disruption: Discriminating criteria and 
representative images. Table illustrates the spectrum of mitochondrial morphologies as 
described. To be rated as intact, mitochondria were generally elongated and had intact outer 
membrane and clear abundant cristae. Mitochondria were rated as showing mild damage if they 
showed evidence of early swelling and some loss of cristae but with an intact outer membrane 
(blue arrows highlight sparse cristae), and were considered to be severely damaged if there 
was apparent disruption of the outer membrane (red arrows); virtually all mitochondria with 
outer membrane rupture showed no discernable cristae. Such severely damaged mitochondria 
also displayed a spectrum of damage, ranging from early membrane rupture (left) to substantial 
rupture with loss of mitochondria contents (middle) or complete absence of membrane (right).  
B.  Mitochondrial damage progresses with increasing recovery time.  To assess possible 
progression of mitochondrial disruption over time after ischemia, we re-examined the same post-
ischemic images (as in Fig. 3), only evaluating the mitochondria that both appeared damaged 
and contained Zn2+ precipitates. Each mitochondrion was rated as mildly damaged if it was 
judged to have an intact outer membrane (OM; blue) or severely damaged if its OM was 
disrupted (red). Note the substantial progression of mitochondrial disruption over time, with a far
greater percentage of mitochondria showing OM disruption after 4 h than after 1 h recovery.  
Bars show percentage of injured mitochondria in each category (intact or disrupted OM), and 
represent mean ± SEM from 3 – 4 independent animals (≥ 55 mitochondria counted from ≥ 10 
sections, each animal;  ** indicates p < 0.01 by 2-tailed student’s t test).  
     Thus, present observations reveal that both the presence of Zn2+ accumulation within 
mitochondria and the extent of damage of the Zn2+ containing mitochondria are progressive in 
the hours after an episode of transient global ischemia. Whereas this does not prove that the 
Zn2+ causes the mitochondrial damage, the data are certainly consistent with a model we have 
proposed based upon recent hippocampal slice studies [19, 22] wherein progressive Zn2+ 
accumulates in mitochondria both during and for a considerable period of time after the ischemic
episode, contributing to their progressive damage and disruption. 
Discussion
Summary of findings
Despite strong evidence for Zn2+ contributions to neuronal injury in ischemia and after prolonged 
seizures, with accumulation of labile Zn2+ in many degenerating neurons and neuroprotective 
effects of Zn2+ chelation, as well as numerous clues that mitochondria are likely to be important 
sites of injurious Zn2+ effects, the relationship between mitochondrial Zn2+ accumulation, 
mitochondrial disruption and neuronal injury in vivo has not been previously examined. The 
present study is the first to use the Timm’s labeling approach – which yields electron dense silver
deposits at sites of labile Zn2+ accumulation – in order to examine the redistribution of Zn2+ in 
CA1 pyramidal neurons after in vivo TGI at the ultrastructural level. Notably, in these post-
ischemic neurons, we found a strong relationship between the appearance of Timm’s deposit 
within mitochondria with their swelling and structural disruption. This observation provides new 
support to the idea that the Zn2+ contributes to the mitochondrial damage / dysfunction seen in 
these neurons. Furthermore, examination at 2 time points after TGI revealed a progression in 
both numbers of damaged and Zn2+ containing mitochondria as well as in the degree of their 
disruption. This delayed temporal evolution correlates with the delayed injury associated with 
mitochondrial disruption that is characteristic of CA1 pyramidal neurons after ischemia [23-25], 
and suggests the possibility that the mitochondrial Zn2+ accumulation and its consequences may 
be progressive events during the hours post-ischemia that are amenable to delayed therapeutic 
interventions.  
Zn2+ in ischemic hippocampal injury
     As noted above, a small portion of brain Zn2+ is loosely bound and can be detected 
histochemically using Timm’s labeling or visualized with membrane permeable fluorescent 
markers; under normal conditions, this pool largely comprises Zn2+ present in presynaptic 
vesicles of some excitatory pathways (most prominently in large mossy fiber boutons) [8, 12]. 
Thus, observations that labile Zn2+ accumulates in injured and degenerating neurons after 
prolonged seizures or ischemia and that these effects were attenuated by an extracellular Zn2+ 
chelator led to the presumption that they resulted from presynaptic Zn2+ release and its 
“translocation” into the postsynaptic neurons [3-5]. This idea was tested via use of mice lacking 
the ZnT3 vesicular Zn2+ transporter, which are entirely lacking in presynaptic vesicular Zn2+ [14]. 
Surprisingly, seizure induced Zn2+ accumulation and injury to CA1 pyramidal neurons was 
actually increased in ZnT3 knockout mice, indicating a distinct non-synaptic source of toxic Zn2+ 
accumulation in these neurons [31].  
     A likely candidate source was Zn2+ that is bound to Zn2+-buffering proteins like MT-III (the 
primary metallothionein isoform in neurons) [32]. Indeed, studies in neuronal culture revealed 
that strong Zn2+ mobilization from these proteins could trigger Zn2+-dependent neuronal injury in 
the absence of extracellular Zn2+ entry [33, 34]. The generation of MT-III knockouts provided a 
model to directly examine the contributions of Zn2+ release from this protein [35]. In vivo seizure 
studies, as well as hippocampal slice OGD studies, using both ZnT3 and MT-III KO’s highlighted 
distinct contributions of these pools of Zn2+ to the Zn2+ accumulation and injury that occurred, 
with mobilization from MT-III predominating in CA1, but with presynaptic release and 
translocation into postsynaptic neurons appearing to predominate in CA3 [15, 20, 22], which 
receives strong synaptic input from the Zn2+ rich mossy fiber terminals, and in contrast to CA1 
neurons are preferentially injured after prolonged limbic seizures. 
Mitochondria are likely to be important targets of Zn2+ effects
     Despite the considerable evidence that “excitotoxic” mechanisms are important contributors 
to neurodegeneration occurring after acute brain insults including ischemia, trauma and 
prolonged seizures, many downstream mechanisms have been implicated and there are as yet 
no neuroprotective treatments that have shown clear benefit in humans. As discussed, early 
studies focused on the key role of Ca2+ entry through highly Ca2+ permeable NMDA channels. 
Studies of relevant downstream mechanisms highlighted mitochondria as a likely important site 
of Ca2+ effects, with Ca2+ entering mitochondria through the mitochondrial Ca2+ uniporter (MCU), 
and with sufficiently large mitochondrial loads, triggering deleterious effects including reactive 
oxygen species generation and opening of the permeability transition pore, leading to release of 
apoptotic mediators including cytochrome C [36]. However, it has also become apparent that 
Zn2+ has very potent effects on mitochondria. This slow recognition of likely Zn2+ contributions 
reflects in part the relatively recent availability of Zn2+ selective indicators [37]. Indeed, virtually 
all the available “Ca2+ indicators” respond to Zn2+ with greater potency, a factor that likely led to 
the mistaken attribution of some Zn2+ effects to Ca2+ [38, 39].
     In many studies on isolated mitochondria and cultured neurons, application of Zn2+ appeared 
to disrupt mitochondrial function with a high degree of potency [40-44]. However, some studies 
have found Zn2+ to induce effects on mitochondria with more modest potency, and clues have 
emerged to factors underlying these divergent results [for review see [19]]. One key variable 
concerns the levels of free Zn2+ achieved in intact neurons upon exogenous exposure. This 
depends both upon the route of Zn2+ entry [44] but also critically upon the integrity of Zn2+ 
buffering by MTs and related peptides [18, 43, 45]. Another likely variable concerns Zn2+ 
interactions with Ca2+, with synergism between effects of these ions on mitochondria [18, 42, 
46], and possible dependence upon Ca2+ for Zn2+ to enter mitochondria through the MCU [47-50].
     Whereas above studies of Zn2+ effects on mitochondria applied Zn2+ to isolated mitochondria 
or cultured neurons, there is also evidence that endogenous Zn2+ accumulates in mitochondria, 
contributing to their dysfunction after in vivo ischemia [6, 17].  In addition, studies in our acute 
hippocampal slice OGD ischemia model provide evidence that early Zn2+ uptake into 
mitochondria via the MCU occurs upstream from and contributes to the subsequent sharp 
terminal Ca2+ rise [20, 21]. More recently, we have subjected slices to sublethal OGD, terminating
the exposure shortly after the initial Zn2+ rise but before the terminal Ca2+ rise, in order to model 
events that may occur after transient in vivo ischemia. Interestingly, consistent with present 
observations after in vivo TGI, we found evidence for delayed and progressive Zn2+ uptake into 
mitochondria of CA1 pyramidal neurons after OGD termination which appeared to contribute to 
delayed mitochondrial swelling. In contrast, in CA3 neurons mitochondrial Zn2+ recovered rapidly 
after OGD termination [22].  
Conclusions and Future Directions
     The development of neuroprotective interventions for stroke has presented an extremely 
difficult challenge, for both logistical reasons and incomplete understanding of critical events in 
the injury cascade. Studies over the past two decades have made it progressively clear that Zn2+ 
is an important ionic mediator of the excitotoxic injury cascade in CA1 as well as in many 
forebrain neurons in which it accumulates. Paralleling the evolving evidence for Zn2+ 
contributions in ischemia, there has been a rapid increase in understanding of ways in which Zn2+
injures neurons, and in particular, emerging clues that mitochondria might be important targets 
of its early effects, with compelling clues from both in vivo and slice models highlighting large 
and long lasting effects after transient ischemia in CA1 [19].  
    Yet, until now, no study has specifically examined the relationship between mitochondrial Zn2+ 
accumulation, mitochondrial disruption and neuronal injury after in vivo ischemia. Such a study 
requires an ultrastructural approach, to correlate Zn2+ accumulation with organelle morphology 
at the individual mitochondrion level, and the presently employed Timm’s labeling (to fix Zn2+ in 
situ) combined with TEM would seem ideally suited for such an investigation. Present findings in 
a rat TGI model demonstrate, for the first time, progressive Zn2+ accumulation in CA1 
mitochondria to be strongly correlated with their physical disruption. While this does not in itself 
indicate causation, it provide new support for a possible direct contributory role of the 
mitochondrial Zn2+ in the delayed mitochondria damage and cell death that are characteristic of 
CA1 [23-25].  
     Future aims will seek to assess potential therapeutic utility of targeting these early events. 
Relevant questions include the nature of interventions that may provide benefit, the temporal 
window of opportunity to intervene, and the definition of contributions of Zn2+ / mitochondrial 
interactions in neuronal populations other than CA1 in which early Zn2+ accumulation occurs. We 
hope these insights will aid the development of therapeutic interventions that improve outcomes
when delivered after ischemia.  
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